Shine-On BioMedical Co.,Ltd.

NT$55.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6926Healthcare
Country Taiwan
PE (Fwd) •••
TSR 4Y CAGR (4.49%)
Div yield —
ROE (20.60%)
Biotechnology
Beta (5Y) (0.08)
PE TTM —
TSR TTM (20.14%)
Mkt cap NT$2.764B
ROIC (13.86%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$67
19.89%
(34.19%)
Hold 7|9|7|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.60
0.66
0.67
0.64
(3.17%)
11.54%
5.54%
6.12%
RevenueNT$M
168.3
171.5
172.3
171.1
8.70%
9.88%
5.21%
0.55%
Peers (US$84.68M)
Cap (US$)
PE
88.97M
—
84.80M
3.385x
Capital
TTM
5Y
10Y
Leveragex
0.775
0.115
0.087
EBIT/Intx
9.353
0.112
0.103
Own earn%
(20.33)
(44.02)
(41.46)
Sh yield%
34.97
23.68
24.03
Owners
Insiders/Inst%
6.52
24.75
Short interest%
1.13
SBC / revenue%
0.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
14–17
$1 testx
0.0
Incr. ROIC%
7